Puma Biotechnology
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Amendment No. 2 to License Agreement dated October 29, 2020, | PUMA BIOTECHNOLOGY, INC. | Business Contracts | Justia
Puma Biotechnology
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Puma Biotech punts near $300 million on Takeda discard
Puma Biotechnology
Puma Biotechnology
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug - TheStreet
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Should You Buy Puma Biotechnology Inc (PBYI) Stock After it Has Gained 6.09% in a Week?
Does Puma's quick Nerlynx launch play into its buyout prospects? | Fierce Pharma
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology, Inc. (PBYI) Company Information - Simply Wall St
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Puma Biotechnology, Inc.
Puma Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Puma Biotechnology, Inc. - PBYI
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
